Analysts Are Bullish on These Healthcare Stocks: EyePoint Pharmaceuticals (EYPT), BrightSpring Health Services, Inc. (BTSG)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on EyePoint Pharmaceuticals (EYPT – Research Report), BrightSpring Health Services, Inc. (BTSG – Research Report) and Brookdale Senior Living (BKD – Research Report) with bullish sentiments.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
EyePoint Pharmaceuticals (EYPT)
In a report released today, Graig Suvannavejh from Mizuho Securities reiterated a Buy rating on EyePoint Pharmaceuticals, with a price target of $33.00. The company’s shares closed last Friday at $13.52.
According to TipRanks.com, Suvannavejh is a 5-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for EyePoint Pharmaceuticals with a $31.50 average price target, implying an 115.0% upside from current levels. In a report released today, TipRanks – Google also upgraded the stock to Buy with a $15.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
BrightSpring Health Services, Inc. (BTSG)
BTIG analyst David Larsen maintained a Buy rating on BrightSpring Health Services, Inc. today and set a price target of $55.00. The company’s shares closed last Friday at $39.27.
According to TipRanks.com, Larsen is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
BrightSpring Health Services, Inc. has an analyst consensus of Strong Buy, with a price target consensus of $45.00, which is a 14.6% upside from current levels. In a report issued on January 30, TipRanks – xAI also upgraded the stock to Buy with a $44.00 price target.
Brookdale Senior Living (BKD)
Bank of America Securities analyst Joanna Gajuk reiterated a Buy rating on Brookdale Senior Living today and set a price target of $18.00. The company’s shares closed last Friday at $15.00.
According to TipRanks.com, Gajuk is a 3-star analyst with an average return of
Brookdale Senior Living has an analyst consensus of Strong Buy, with a price target consensus of $16.13, which is an 11.5% upside from current levels. In a report issued on January 29, TipRanks – Google also upgraded the stock to Buy with a $14.50 price target.
